Hyperglycemia in Medical Technology
Navigation Links
Hyperglycemia in Medical Technology
... (sugar) control for critical care patients with hyperglycemia (high blood glucose) does not improve outcomes ... national movement viewing the management of hyperglycemia in hospitals as a quality care measure," Dr. Etie ... and up-to-date recommendations for treatment of hyperglycemia in the hospital.
"The central goal of the ...
... either with or without diabetes, developed hyperglycemia of grade 2 or higher (P=0.002 for diabetic ... (P=0.675). However, the development of hyperglycemia or hypercholesterolemia did not have affect on ... The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for ...
... TD may remit, partially or completely hyperglycemia and diabetes mellitus -- Hyperglycemia, in some ... testing. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. There have been few reports of hyperglycemia with ABILIFY ABILIFY may be associated with ...
... partially or completely, if antipsychotic treatment is withdrawn. hyperglycemia and Diabetes: Hyperglycemia, some cases extreme and associated with ... at the beginning of and during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. ...
... in ICU settings. "We are witnessing an evolution in the management of hyperglycemia in inpatient settings," Dr. Etie S. Moghissi, AACE Chair of the Inpatient ... to discharge from the hospital. "The responsibility for management of hyperglycemia shifts from the health care team to the patient following hospital ...
... during treatment with TORISEL. The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for an increase in the dose ... abnormalities (incidence greater than or equal to 30%) are anemia (94%), hyperglycemia (89%), hyperlipemia (87%), hypertriglyceridemia (83%), elevated alkaline ...
... during treatment with TORISEL. The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for an increase in the dose ... abnormalities (incidence greater than or equal to 30%) are anemia (94%), hyperglycemia (89%), hyperlipemia (87%), hypertriglyceridemia (83%), elevated alkaline ...
... of and periodically during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. A potentially fatal ... (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose greater than or equal to 126 mg/dL) was observed in 10.7% ...
... of and periodically during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. A potentially fatal ... (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose greater than or equal to 126 mg/dL) was observed in 10.7% ...
... of and periodically during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. A potentially fatal ... (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose greater than or equal to 126 mg/dL) was observed in 10.7% ...
... Monia, S. Bhanot. A Newly Identified Role of Nuclear Receptor Corepressor, SMRT (Silencing Mediator of Retinoid and Thyroid) in Improving hyperglycemia and Insulin Sensitivity in Obese and Diabetic Mice (Late-Breaking Poster) Authors: S.K. Pandey, S.F. Murray, S. Guo, L.M. Watts, S.L. Booten, ...
... adverse events were biliary disorders (62%), gastrointestinal disorders (14% to 38%), and injection-site pain (20% to 50%). Hypoglycemia (4%), hyperglycemia (27%), sinus bradycardia (19%), conduction abnormalities (9%), and arrhythmias (3%) have been reported. Additional adverse reactions identified in ...
... control; those with risk factors for diabetes should undergo baseline and periodic fasting blood glucose testing. Patients who develop symptoms of hyperglycemia during treatment should undergo fasting blood glucose testing. Undesirable alterations in lipids have been observed with olanzapine ...
... vomiting (21%). The most common ( > 10%) Grade 3/4 adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%), and hyperglycemia (11%). In accelerated phase patients, the most commonly reported adverse reactions ( > 10%) were rash (28%), pruritus (20%), and constipation ...
... and vomiting (21%). The most common (>10%) Grade 3/4 adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%) and hyperglycemia (11%). In accelerated phase patients, the most commonly reported adverse reactions (>10%) were rash (28%), pruritus (20%) and constipation (18%). ...
... who are starting on atypical antipsychotics should undergo baseline and periodic fasting blood glucose testing. Patients who develop symptoms of hyperglycemia during treatment should undergo fasting blood glucose testing. Undesirable alterations in lipids have been observed with olanzapine use. Clinical ...
... diluted or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor metabolic ...
... and vomiting (21%). The most common ( >10%) Grade 3/4 adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%), and hyperglycemia (11%). In accelerated phase patients, the most commonly reported adverse reactions ( >10%) were rash (28%), pruritus (20%), and constipation (18%). ...
... to the outpatient clinic facilitated by a diabetes care coordinator. Approximately 40% of adult hospitalized patient at University Hospital have hyperglycemia with only 5% receiving follow-up outpatient care in the diabetes clinic. The University Hospital's goal is to fill the gap in their diabetes care by ...
... newly diagnosed hyperglycemia (as defined by having an HbA1c of greater than 6.0 percent or a new fasting glucose of more than 110mg/dL). Worsening hyperglycemia (defined as greater than a one percent increase in HbA1c) was 37 percent less likely (p<0.001) in the Ranexa treated group and no increased ...
... encephalopathy in patients with deficiencies in enzymes of the urea cycle. The most common adverse reactions are vomiting (9%), hypokalemia (7%), hyperglycemia (7%), convulsions (6%), and mental impairments (6%). Do not administer to patients with known hypersensitivity to sodium phenylacetate or ...
... treated with aripiprazole - hyperglycemia and diabetes mellitus-Hyperglycemia, in some ... testing. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. There have been few reports of hyperglycemia with aripiprazole Aripiprazole may be ...
... dyspnea (20% vs 15%), tremor (20% vs 7%), decreased weight (18% vs 14%), thrombocytopenia (17% vs 10%), rash (16% vs 8%), back pain (15% vs 14%), hyperglycemia (15% vs 14%), and muscle weakness (15% vs 15%). Myelodysplastic Syndromes: Other adverse reactions reported in del 5q MDS patients (REVLIMID(R)): ...
... are at risk for diabetes should undergo fasting blood glucose testing at the beginning of and during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. Precautions include the risk of seizures, orthostatic hypotension, and cataracts. Examination of ...
... diluted or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor metabolic ...
... or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor ...
... either with or without diabetes, developed hyperglycemia of grade 2 or higher (P=0.002 for diabetic ... (P=0.675). However, the development of hyperglycemia or hypercholesterolemia did not have affect on ... The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for ...
... TD may remit, partially or completely hyperglycemia and diabetes mellitus -- Hyperglycemia, in some ... testing. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. There have been few reports of hyperglycemia with ABILIFY ABILIFY may be associated with ...
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
... treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia including polydipsia, polyuria, palyphagia, and weakness. Patients who develop symptoms of hyperglycemia during treatment should undergo fasting blood glucose testing. ...... partially or completely, if antipsychotic treatment is withdrawn. hyperglycemia and Diabetes: Hyperglycemia, some cases extreme and associated with ... at the beginning of and during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. ...
... in ICU settings. "We are witnessing an evolution in the management of hyperglycemia in inpatient settings," Dr. Etie S. Moghissi, AACE Chair of the Inpatient ... to discharge from the hospital. "The responsibility for management of hyperglycemia shifts from the health care team to the patient following hospital ...
... during treatment with TORISEL. The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for an increase in the dose ... abnormalities (incidence greater than or equal to 30%) are anemia (94%), hyperglycemia (89%), hyperlipemia (87%), hypertriglyceridemia (83%), elevated alkaline ...
... during treatment with TORISEL. The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for an increase in the dose ... abnormalities (incidence greater than or equal to 30%) are anemia (94%), hyperglycemia (89%), hyperlipemia (87%), hypertriglyceridemia (83%), elevated alkaline ...
... of and periodically during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. A potentially fatal ... (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose greater than or equal to 126 mg/dL) was observed in 10.7% ...
... of and periodically during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. A potentially fatal ... (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose greater than or equal to 126 mg/dL) was observed in 10.7% ...
... of and periodically during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. A potentially fatal ... (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose greater than or equal to 126 mg/dL) was observed in 10.7% ...
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
... during treatment with TORISEL. The use of TORISEL is likely to result in hyperglycemia and hyperlipemia. This may result in the need for an increase in the dose ... abnormalities (incidence greater than or equal to 30%) are anemia (94%), hyperglycemia (89%), hyperlipemia (87%), hypertriglyceridemia (83%), elevated alkaline ...SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
... of and periodically during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. A potentially fatal ... hypotension (7% vs 5%). In long-term clinical trials of quetiapine, hyperglycemia (fasting glucose Greater Than or Equal To 126 mg/dl) was observed in 10.7% ...... Monia, S. Bhanot. A Newly Identified Role of Nuclear Receptor Corepressor, SMRT (Silencing Mediator of Retinoid and Thyroid) in Improving hyperglycemia and Insulin Sensitivity in Obese and Diabetic Mice (Late-Breaking Poster) Authors: S.K. Pandey, S.F. Murray, S. Guo, L.M. Watts, S.L. Booten, ...
Boehringer Ingelheim Unveils Diabetes Pipeline
... 2 diabetes patients when added to onogoing metformin therapy. ADA, 05-09 June 2009, New Orleans, U.S.A. (2) Nathan DM et al. Medical Management of hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care 21:1-11, 2008. (3) Clinicaltrials.gov. ...... adverse events were biliary disorders (62%), gastrointestinal disorders (14% to 38%), and injection-site pain (20% to 50%). Hypoglycemia (4%), hyperglycemia (27%), sinus bradycardia (19%), conduction abnormalities (9%), and arrhythmias (3%) have been reported. Additional adverse reactions identified in ...
... control; those with risk factors for diabetes should undergo baseline and periodic fasting blood glucose testing. Patients who develop symptoms of hyperglycemia during treatment should undergo fasting blood glucose testing. Undesirable alterations in lipids have been observed with olanzapine ...
... vomiting (21%). The most common ( > 10%) Grade 3/4 adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%), and hyperglycemia (11%). In accelerated phase patients, the most commonly reported adverse reactions ( > 10%) were rash (28%), pruritus (20%), and constipation ...
... and vomiting (21%). The most common (>10%) Grade 3/4 adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%) and hyperglycemia (11%). In accelerated phase patients, the most commonly reported adverse reactions (>10%) were rash (28%), pruritus (20%) and constipation (18%). ...
... who are starting on atypical antipsychotics should undergo baseline and periodic fasting blood glucose testing. Patients who develop symptoms of hyperglycemia during treatment should undergo fasting blood glucose testing. Undesirable alterations in lipids have been observed with olanzapine use. Clinical ...
... diluted or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor metabolic ...
... and vomiting (21%). The most common ( >10%) Grade 3/4 adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%), and hyperglycemia (11%). In accelerated phase patients, the most commonly reported adverse reactions ( >10%) were rash (28%), pruritus (20%), and constipation (18%). ...
Drug Combo Could Lower Diabetes Complications and Costs
... diabetes have health implications for mother and child that extend far beyond pregnancy. However, for women with pre-existing diabetes, maternal hyperglycemia that exists prior to pregnancy and continues into the first 8 weeks of gestation exposes the fetus to an increased risk of miscarriage and birth ...... to the outpatient clinic facilitated by a diabetes care coordinator. Approximately 40% of adult hospitalized patient at University Hospital have hyperglycemia with only 5% receiving follow-up outpatient care in the diabetes clinic. The University Hospital's goal is to fill the gap in their diabetes care by ...
... newly diagnosed hyperglycemia (as defined by having an HbA1c of greater than 6.0 percent or a new fasting glucose of more than 110mg/dL). Worsening hyperglycemia (defined as greater than a one percent increase in HbA1c) was 37 percent less likely (p<0.001) in the Ranexa treated group and no increased ...
... encephalopathy in patients with deficiencies in enzymes of the urea cycle. The most common adverse reactions are vomiting (9%), hypokalemia (7%), hyperglycemia (7%), convulsions (6%), and mental impairments (6%). Do not administer to patients with known hypersensitivity to sodium phenylacetate or ...
Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
... with caution in patients with a known sulfonamide allergy. -- New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus, hyperglycemia and increased bleeding (in patients with hemophilia) have been reported in patients taking protease inhibitors. A causal relationship between ...DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
... Preclinical and clinical studies have suggested that a link exists between high cortisol levels and visceral adiposity, insulin resistance, and hyperglycemia -- common elements of T2DM and metabolic syndrome. There are no cortisol synthesis inhibitors on the market today, potentially making DIO-902 a ...One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
... M, Strumph P, Pimenta W, Veneman T, Jenssen T and Bolli G. "Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp." J Clin Endocrinol Metab 1992: 75(2), 379-382. 4 The International Diabetes Federation Diabetes Atlas. Available at: ....One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
... M, Strumph P, Pimenta W, Veneman T, Jenssen T and Bolli G. "Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp." J Clin Endocrinol Metab 1992: 75(2), 379-382. 4 The International Diabetes Federation Diabetes Atlas. Available at: ....... treated with aripiprazole - hyperglycemia and diabetes mellitus-Hyperglycemia, in some ... testing. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. There have been few reports of hyperglycemia with aripiprazole Aripiprazole may be ...
Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
... treated with aripiprazole -- hyperglycemia and diabetes mellitus -- Hyperglycemia, in some ... testing. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. There have been few reports of hyperglycemia with aripiprazole Aripiprazole may be ...... dyspnea (20% vs 15%), tremor (20% vs 7%), decreased weight (18% vs 14%), thrombocytopenia (17% vs 10%), rash (16% vs 8%), back pain (15% vs 14%), hyperglycemia (15% vs 14%), and muscle weakness (15% vs 15%). Myelodysplastic Syndromes: Other adverse reactions reported in del 5q MDS patients (REVLIMID(R)): ...
... are at risk for diabetes should undergo fasting blood glucose testing at the beginning of and during treatment. Patients who develop symptoms of hyperglycemia should also undergo fasting blood glucose testing. Precautions include the risk of seizures, orthostatic hypotension, and cataracts. Examination of ...
Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
... (6%); creatinine elevation (5%); alopecia (1%-13%); and dyspnea (1%-7%). The most common adverse events (all grades) were paresthesias (38%); hyperglycemia (30%); infection (18%-28%); and constipation (17%-28%). The most severe adverse events (grades 3/4) with GEMZAR plus carboplatin for the treatment ...... diluted or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor metabolic ...
... or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor ...
Other ContentstrypanosomiasistryptophantryptophantryptophantryptophantubaltubaltuberculintuberculintuberculosistuberculosistuberculosistuberculosistuberculosistuberculosisOther TagsKenyanMyanmarPreeclampsiaArrestMcDonald
(Date:11/6/2009)... generally live in harmony with their arboreal hos...ut of space in their trees of choice, the ants can...earch, published in the November issue of the Ame...nts bore into live trees, and it reopens a centuri... plants. , Ants and certain species of plants an...
(Date:11/5/2009)...searchers at Yale University have developed synthe...ne response to HIV and HIV-infected cells, as well...ished online in the Journal of the American Chemi...oaches for these diseases. , The molecules cal...ARM-H) and "antibody-recruiting molecule targeting...
(Date:11/4/2009)...idors in the cities of Long Beach and Riverside ar...entable childhood asthma, and the true impact of a... likely been underestimated, according to research.... , The study, which appears in an online editi...imated that nine percent of all childhood asthma c...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2Kaiser Workers Statewide Campaign Starts Tuesday 55751 1Kaiser Workers Statewide Campaign Starts Tuesday 55751 2CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 1CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 2CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 3CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 4CPF Submits Comments to CMS to Save Only Effective Therapy Available to PF Patients 55748 5VirtualScopics to Present at the Rodman 26 Renshaw Annual Global Investment Conference 55746 1VirtualScopics to Present at the Rodman 26 Renshaw Annual Global Investment Conference 55746 2(Date:11/9/2009)...abbits implanted with new cells regained sexual fu...9 (HealthDay News) -- Researchers were able to res...es by growing new penile tissue in the lab and imp...an application is a ways off, researchers say the ...ectile dysfunction in men. , "We were able to s...
(Date:11/9/2009)... Course, to be Offered in ...sic Toolkit , Cambridge, ... of Physicians for Human Rights (PHR) first inspec...ghanistan , he realized he would need a team of ex...cumenting the site properly was a key first step i...
(Date:11/9/2009)..., March of Dimes Names 2010 National Ambassad...USNewswire/ -- Joshua Hoffman of Weston, Fla., was...ans that doctors could not say whether he would su...ar. Today, the 6-year-old was named March of Dimes...lanie Hoffman, recalls, "My first minutes of mothe...
(Date:11/9/2009)...tudy didn,t answer question of why this is so, how...s) -- After a lumpectomy, women with very dense br...he affected breast, a new study shows. , Breast... risk of developing breast cancer, and experts hav...sociated with an increased risk of cancer recurren...
(Date:11/9/2009)..., PITTSFIELD, Maine, Nov. 9 At ...nts in Maine are increasingly concerned about find...ompetitive Medicare option for 2010. ,, The Tod... (PPO) Medicare Advantage plan provides a cost-eff...edicare or a Medicare Supplement plan. People wit...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2[0] Scientists Grow New Penile Tissue in the Lab[2] Physicians for Human Rights Offers Training in Crime Scene Documentation[0] Six-Year-Old Survivor Fights for Preemies Like Himself[0] Dense Breasts Raise Risk of Cancer Recurrence[0] Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option
SubliminalForearmKenyanMyanmarPreeclampsiaBicycleAngelinaSwearingPolyunsaturatedDiclofenacArrestAnonymityMcDonaldPramod
Other Tagsexpected 2expected 3expected 4expected 5expected 6expected 7expected 8expected 9expected 10biotechnology 2biotechnology 3biotechnology 4biotechnology 5giants 2pharmaceutical 2pharmaceutical 3pharmaceutical 4pharmaceutical 5pharmaceutical 6pharmaceutical 7pharmaceutical 8pharmaceutical 9pharmaceutical 10case 2case 3case 4case 5case 6case 7case 8case 9case 10landmark 2landmark 3landmark 4landmark 5raise 2raise 3raise 4raise 5raise 6raise 7concentrations 2concentrations 3concentrations 4concentrations 5concentrations 6concentrations 7concentrations 8concentrations 9concentrations 10picture 2picture 3picture 4picture 5picture 6picture 7picture 8picture 9picture 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |